Chemoinformaics analysis of 2-C-methyl-D-erythritol
| Molecular Weight | 136.147 | nRot | 3 |
| Heavy Atom Molecular Weight | 124.051 | nRig | 0 |
| Exact Molecular Weight | 136.074 | nRing | 0 |
| Solubility: LogS | 0.208 | nHRing | 0 |
| Solubility: LogP | -1.488 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 19.5595 |
| nHD | 4 | BPOL | 12.0385 |
| QED | 0.364 |
| Synth | 3.748 |
| Natural Product Likeliness | 2.342 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.009 |
| HIA | 0.017 |
| CACO-2 | -5.181 |
| MDCK | 0.00440681 |
| BBB | 0.403 |
| PPB | 0.114786 |
| VDSS | 0.449 |
| FU | 0.80127 |
| CYP1A2-inh | 0.012 |
| CYP1A2-sub | 0.09 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.315 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.069 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.099 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.08 |
| CL | 2.616 |
| T12 | 0.723 |
| hERG | 0.047 |
| Ames | 0.035 |
| ROA | 0.003 |
| SkinSen | 0.117 |
| Carcinogencity | 0.03 |
| EI | 0.95 |
| Respiratory | 0.011 |
| NR-Aromatase | 0.021 |
| Antiviral | No |
| Prediction | 0.943618 |